Haemodynamic-guided HF management ‘may cut hospitalisations’
Trial outcomes were affected by the COVID-19 pandemic, with only early data showing a significant effect, researchers say.
Tag: ESC Congress 2021
Valsartan ‘shows promise’ in hypertrophic cardiomyopathy
A phase 2 trial suggests early treatment may attenuate cardiac remodelling.
Breathing difficulties ‘under-rated as a signal of imminent cardiac arrest’
More attention should be paid to this prodromal symptom when cited in emergency calls, researcher says.
Flu vax in hospital post-MI reduces further events: study
Largest trial to date underscores the value of protecting patients with heart disease from influenza.
Stenting and carotid endarterectomy ‘on a par’ for long-term stroke risk
UK-led randomised controlled trial determi…
